Tobacco control

Keeping tobacco cheap: how tobacco companies undermine government tax measures.

Tobacco control

Malone RE

Assessment of industry data on pulmonary and immunosuppressive effects of IQOS.

Tobacco control

Moazed F, Chun L, Matthay MA, Calfee CS, Gotts J

IQOS: examination of Philip Morris International's claim of reduced exposure.

Tobacco control

St Helen G, Jacob Iii P, Nardone N, Benowitz NL

Electronic cigarette chemicals transfer from a vape shop to a nearby business in a multiple-tenant retail building.

Tobacco control

Khachatoorian C, Jacob Iii P, Benowitz NL, Talbot P

IQOS labelling will mislead consumers.

Tobacco control

McKelvey K, Popova L, Kim M, Lempert LK, Chaffee BW, Vijayaraghavan M, Ling P, Halpern-Felsher B

Possible hepatotoxicity of IQOS.

Tobacco control

Chun L, Moazed F, Matthay M, Calfee C, Gotts J

PMI's own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes.

Tobacco control

Glantz SA

Tobacco company strategies to identify and promote the benefits of nicotine.

Tobacco control

Ling PM, Glantz SA

Role of stakeholders in Nigeria's tobacco control journey after the FCTC: lessons for tobacco control advocacy in low-income and middle-income countries.

Tobacco control

Egbe CO, Bialous SA, Glantz S

Integrating tobacco control into health and development agendas.

Tobacco control

Reddy KS, Yadav A, Arora M, Nazar GP

Pages